| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.7 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.7 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.7 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |